A UK-led study found that the use of menopausal hormone therapy does not increase the risk of dementia. The study appeared in the BMJ.
The study involved the participation of over 100,000 women aged 55 and older, who were diagnosed with dementia during the late-1990s through 2020.
Two UK primary care databases were probed, including CPRD and QResearch.
“After adjusting for the full range of potentially confounding factors, the researchers found no overall associations between use of hormone therapy and risk of dementia, regardless of hormone type, application, dose, or duration of treatment,” a news release of the findings state.
Overall, the findings layout the probability of risks for developing cognitive diseases like Alzheimer’s in women exposed to varying types of menopausal hormone therapy at different durations.
The study uncovered no increase in risks of developing dementia, but did show a slightly higher risk for Alzheimer’s among users of estrogen-progestogen therapies.